Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review-Reference-Cited by-同舟云学术

Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review

Published:2018-04-06 Issue:8 Volume:65 Page:e27065
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Dholaria Hetal G.¹²^ORCID,Davies Amy¹,Kotecha Rishi S.¹²³,Gottardo Nicholas G.¹²³,Walwyn Thomas¹²

Affiliation:

1. Department of Paediatric Haematology and Oncology; Princess Margaret Hospital for Children; Perth Australia

2. Division of Paediatrics, School of Medicine; University of Western Australia; Perth Australia

3. Telethon Kids Cancer Centre; Telethon Kids Institute; University of Western Australia; Perth Australia

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference11 articles.

1. Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation;der Sluis;Haematologica,2016

2. Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961;Panosyan;J Pediatr Hematol Oncol,2004

3. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future;Avramis;Clin Pharmacokinet,2005

4. Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: a meta-analysis and systematic review;Hasan;Pediatr Blood Cancer,2017

5. Comparison of hypersensitivity reactions to PEG-asparaginase in children after intravenous and intramuscular administration;August;J Pediatr Hematol Oncol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower incidence of clinical allergy with PEG‐asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG‐ASP in pediatric patients with acute lymphoblastic leukemia;Hematological Oncology;2021-08-16

2. Comment on “Comparison of hypersensitivity rates to intravenous and intramuscular PEGasparaginase in children with acute lymphoblastic leukemia: A meta‐analysis and systematic review”;Pediatric Blood & Cancer;2021-07-21

3. Premedication prior to PEG‐asparaginase is cost‐effective in pediatric patients with acute lymphoblastic leukemia;Pediatric Blood & Cancer;2021-04-16

4. Reply to: Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review;Pediatric Blood & Cancer;2018-04-25